Premenstrual Pain
Conditions
Brief summary
These will be no effect of transcutaneous electrical acupoint stimulation on premenstrual syndrome Does transcutaneous electrical acupoint stimulation affect premenstrual syndrome (PMS)?
Detailed description
Premenstrual syndrome is a collection of emotional, physiological, and behavioral symptoms that develop around the end of the luteal phase and fade away with or after menstruation Due to limited evidence on the efficacy of sustained progesterone and the side effects of antidepressant and anxiolytics, in some cases, alternative therapies are recommended for patients with PMS TEAS may be more effective than other forms of transcutaneous electrical nerve stimulation (TENS) in modulating brain activity because acupoint areas contain relatively denser neural and neuroactive components than non-acupoint areas TEAS has been reported to have similar efficacy as acupuncture, electrical acupuncture, and TENS
Interventions
DEVICETranscutaneous electrical nerve stimulation (TENS)
Control group will receive TEAS on sham acupoint daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles Study group will receive TEAS on neurogenic acupoints daily from 3 days before menstruation to the 4th day of menstruation for 3 consequent menstrual cycles
Sponsors
Cairo University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 25 Years
Healthy volunteers
No
Inclusion criteria
* Their age will range from 18 to 25 years. * The regularity of menstrual cycle is 28-35 days. * All of them suffering from moderate and sever PMS. * All participants are virgin. * Their BMI will range from 25-30 kg\\m2.
Exclusion criteria
* Any pathological findings in the pelvic cavity as PCO, Endometriosis and pelvic inflammatory disease. * Any history of gynecological intervention. * Have any condition impedes the use of electrotherapy. * Receiving sedatives or any medical treatment. * Having irregular menstruation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| pain severity | Up to 3 monthes | The pain intensity will be assessed through visual analogue scale (VAS) for each participant in both groups before and after treatment Each participant will be asked to mark a point on VAS line between the extremes that related to her current pain intensity |
| premenstrual syndrome severity | up to 3 monthes | Participants can differentiate between their experiences of different symptoms during menstrual cycle and they will be assessed before and after treatment using the Menstrual Distress Questionnaire (MDQ) Each participant will be asked to rate their experience of each of the symptoms on the MDQ on a scale ranging from no experience of the symptom to an acute or partially disabling experience of the symptom |
Contacts
Primary ContactAzza Barmoud, professor
Outcome results
None listed